Terminated trial tests new combo for tough blood cancers
NCT ID NCT04809467
Summary
This early-phase study aimed to see if combining two targeted drugs, tafasitamab and parsaclisib, was safe and effective for adults whose non-Hodgkin lymphoma or chronic lymphocytic leukemia had returned or stopped responding to prior treatments. The trial enrolled 54 participants and was designed to find the best dose and check for side effects and early signs of tumor shrinkage. The study was terminated early, and its results are not yet widely available.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AZ DELTA
Roeselare, 08800, Belgium
-
Az Groeninge Campus Kennedylaan
Kortrijk, 08500, Belgium
-
Azienda Ospedaliera Ospedali Riuniti Villa Sofia - Cervello
Palermo, 90146, Italy
-
Azienda Ospedaliero Universitaria Pisana
Pisa, 56126, Italy
-
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
Milan, 20162, Italy
-
Cancer Center For Blood Disorders
Bethesda, Maryland, 20817, United States
-
Centre Henri Becquerel
Rouen, 76038, France
-
Centre Hospitalier Universitaire de Nantes (Chu de Nantes) - Hotel-Dieu
Nantes, 44093, France
-
Centro Integral Oncologico Clara Campal (Ciocc)
Madrid, 28050, Spain
-
Clinical Research Alliance
New Hyde Park, New York, 11042, United States
-
Community Health Network, Inc.
Indianapolis, Indiana, 46250, United States
-
Fondazione Irccs Istituto Nazionale Dei Tumori
Milan, 20133, Italy
-
Grand Hospital de Charleroi
Charleroi, 06000, Belgium
-
Hanusch-Krankenhaus Der Wiener Gebietskrankenkasse
Vienna, 01140, Austria
-
Hopital Sant Pau
Barcelona, 08036, Spain
-
Hospital Clinico Universitario de Salamanca
Salamanca, 37007, Spain
-
Hospital General Universitario Vall D Hebron
Barcelona, 08035, Spain
-
Hospital General Universitario de Valencia
Valencia, 46014, Spain
-
Hospital General Unviersitario de Alicante
Alicante, 03010, Spain
-
Hospital Puerta de Hierro
Majadahonda, 28222, Spain
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitario Central de Asturias
Oviedo, 33011, Spain
-
Hospital Universitario Marques de Valdecilla
Santander, 39008, Spain
-
Hospital Universitario Quironsalud Madrid
Madrid, 28223, Spain
-
Hospital Universitario San Cecilio
Granada, 18016, Spain
-
Hospital Universitario Virgen Del Rocio
Seville, 41015, Spain
-
Ico Institut Catala D Oncologia
Barcelona, 08908, Spain
-
Indiana Blood and Marrow Transplantation
Indianapolis, Indiana, 46237, United States
-
Institut Gustave Roussy
Villejuif, 94805, France
-
Institut Jules Bordet
Brussels, B-1070, Belgium
-
Irccs Istituto Clinico Humanitas
Rozzano, 20089, Italy
-
Istituto Nazionale Tumori Irccs Fondazione Pascale
Naples, 80131, Italy
-
Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori
Meldola, 47014, Italy
-
Jefferson University Hospitals
Philadelphia, Pennsylvania, 19107, United States
-
Justus-Liebig University
Giessen, 35392, Germany
-
Landeskrankenhaus Salzburg
Salzburg, 05020, Austria
-
Norton Cancer Institute
Louisville, Kentucky, 40202, United States
-
Ohio State University
Columbus, Ohio, 43210, United States
-
Ordensklinikum Linz Gmbh Elisabethinen
Linz, A-4020, Austria
-
Ospedale Santa Maria Delle Croci
Ravenna, 48121, Italy
-
S Orsolas University Hospital Seragnoli Institute of Hematology
Bologna, 40138, Italy
-
Universitair Ziekenhuis (Uz) Leuven
Leuven, 03000, Belgium
-
Universitair Ziekenhuis Antwerpen (Uza)
Edegem, 02650, Belgium
-
Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Iii
Mainz, 55131, Germany
-
University Hospital Brest
Brest, 29609, France
-
University Hospital Wurzburg
Würzburg, 97080, Germany
-
University Medical Center Freiburg
Freiburg im Breisgau, 79106, Germany
-
University of Alabama At Birmingham Comprehensive Cancer Center
Birmingham, Alabama, 35205, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
University of Southern California
Los Angeles, California, 90089, United States
Conditions
Explore the condition pages connected to this study.